Clinical studies have shown that TIMP-1 can be applied to treat BBB dysfunction in brain injury [58,59], and in experimental stroke models, the lack of TIMP-1 exacerbates the disruption of the BBB [25,55,60]. The gene discussed is TIMP1; the disease is stroke disorder.